AbsEn.i
Analysis
2020
Racine
Analysis
2020
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Analysis (2020)

Index « AbsEn.i » - entrée « potential »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
potent < potential < potentially  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 97.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000006 (2020) Anna Jakubczyc ; Claus Neurohr[Interstitial lung disease in rheumatic diseases - new therapeutic approaches].
000007 (2020) Danièle Allali ; Marc Blondon ; Pascale Roux-Lombard ; David Spoerl[How to manage giant cell arteritis].
000010 (2020) Aline Pfefferle [Australie] ; Nicholas D. Huntington [Australie]You Have Got a Fast CAR: Chimeric Antigen Receptor NK Cells in Cancer Therapy
000014 (2020) Puja Mehta ; Jessica J. MansonWhat Is the Clinical Relevance of TNF Inhibitor Immunogenicity in the Management of Patients With Rheumatoid Arthritis?
000016 (2020) M. SilbersteinVitamin D: A simpler alternative to tocilizumab for trial in COVID-19?
000020 (2020) Jared Radbel [États-Unis] ; Navaneeth Narayanan [États-Unis] ; Pinki J. Bhatt [États-Unis]Use of tocilizumab for COVID-19 infection-induced cytokine release syndrome: A cautionary case report.
000034 (2020) Angelika Batta ; Bhupinder Singh Kalra ; Raj KhirasariaTrends in FDA drug approvals over last 2 decades: An observational study
000042 (2020) Prakhar Vijayvargiya [États-Unis] ; Zerelda Esquer Garrigos [États-Unis] ; Natalia E. Castillo Almeida [États-Unis] ; Pooja R. Gurram [États-Unis] ; Ryan W. Stevens [États-Unis] ; Raymund R. Razonable [États-Unis]Treatment Considerations for COVID-19: A Critical Review of the Evidence (or Lack Thereof)
000044 (2020) Ernest H. Choy [Royaume-Uni] ; Fabrizio De Benedetti [Italie] ; Tsutomu Takeuchi [Japon] ; Misato Hashizume [Japon] ; Markus R. John [Suisse] ; Tadamitsu Kishimoto [Japon]Translating IL-6 biology into effective treatments
000080 (2020) Maria Valeria Catani ; Isabella Savini ; Valentina Tullio ; Valeria GasperiThe “Janus Face” of Platelets in Cancer
000082 (2020) Eun-Jung Park [Corée du Sud] ; Hyungjin Kim [Corée du Sud] ; Seung Min Jung [Corée du Sud] ; Yoon-Kyoung Sung [Corée du Sud] ; Han Joo Baek [Corée du Sud] ; Jisoo Lee [Corée du Sud]The use of biological disease-modifying antirheumatic drugs for inflammatory arthritis in Korea: results of a Korean Expert Consensus
000084 (2020) Matthew Zirui Tay [Singapour] ; Chek Meng Poh [Singapour] ; Laurent Rénia [Singapour] ; Paul A. Macary [Singapour] ; Lisa F. P. Ng [Singapour, Royaume-Uni]The trinity of COVID-19: immunity, inflammation and intervention
000089 (2020) Jacob J. Adashek [États-Unis] ; Shumei Kato [États-Unis] ; Scott M. Lippman [États-Unis] ; Razelle Kurzrock [États-Unis]The paradox of cancer genes in non-malignant conditions: implications for precision medicine
000092 (2020) Camilla Br Dsgaard Nielsen [Danemark] ; Christian Nielsen [Danemark] ; Mads Nybo [Danemark] ; S Ren Andreas Just [Danemark] ; Pernille Just Vinholt [Danemark]The in vitro effect of antirheumatic drugs on platelet function.
000097 (2020) Weiyi Tan ; Jamil AboulhosnThe cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease
000099 (2020) Carlo Perricone [Italie] ; Paola Triggianese [Italie] ; Elena Bartoloni [Italie] ; Giacomo Cafaro [Italie] ; Angelo F. Bonifacio [Italie] ; Roberto Bursi [Italie] ; Roberto Perricone [Italie] ; Roberto Gerli [Italie]The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19
000101 (2020) Mohammed Shah ; Derek M. Yellon ; Sean M. DavidsonThe Role of Extracellular DNA and Histones in Ischaemia-Reperfusion Injury of the Myocardium
000105 (2020) Peter J. Hotez ; Maria Elena Bottazzi ; David B. CorryThe Potential Role of Th17 Immune Responses in Coronavirus Immunopathology and Vaccine-induced Immune Enhancement
000113 (2020) José M. Carballido [Suisse] ; Camille Regairaz [Suisse] ; Celine Rauld [Suisse] ; Layla Raad [Suisse] ; Damien Picard [Suisse] ; Michael Kammüller [Suisse]The Emerging Jamboree of Transformative Therapies for Autoimmune Diseases
000115 (2020) Philip C. Robinson [Australie] ; Jinoos Yazdany [États-Unis]The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic
000116 (2020) Xi-Ying Wang [République populaire de Chine] ; Fen Zhang [République populaire de Chine] ; Chi Zhang [République populaire de Chine] ; Liang-Rong Zheng [République populaire de Chine] ; Jian Yang [République populaire de Chine]The Biomarkers for Acute Myocardial Infarction and Heart Failure

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "potential" 

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "potential" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    potential
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021